Work

Cancer-associated Venous Thromboembolic Events

Year: 2025

Type: article

Abstract: Cancer patients are at a four- to 6.5-fold higher risk of developing venous thromboembolic events (VTEs), with risk factors such as surgery, hospitalization, and chemotherapy. The pathophysiology of cancer-associated thrombosis (CAT) involves the direct or indirect activation of the coagulation cascade by the release of tumor-derived procoagulant factors (microparticles, tissue factors, cancer procoagulants, and platelet agonists). We have reviewed the published literature from the references on CAT.

Source: Journal of Vascular Surgery Venous and Lymphatic Disorders

DOI: 10.1016/j.jvsv.2024.102050

Authors: Atul Laddu, Naha Sahithi, Siddharth Ranjan, Vedanshi Kumar, Ruth Bush

Institution: The University of Texas Medical Branch at Galveston

Language: English

Topic: Venous Thromboembolism Diagnosis and Management

Subfield: Internal Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,400